Aller au contenu principal
Profil bibliographique

John E. Mamatis

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
105Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Viral Infections and Immunology ResearchSignaling Pathways in DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfluenza Virus Research Studies

Les publications récentes

Accès ouvert 2025 article OpenAlex

RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?

Sophia K. Stegeman, Olena Kourko, Heather Amsden, Isabella E Pellizzari Delano et autres

BACKGROUND: The interactions between viruses and the host immune response are nuanced and intricate. The cytokine response arguably plays a central role in dictating the outcome of virus infection, balancing inflammation, and healing, which is crucial to resolving infection without destructive immunopathologies. …

ca (code pays fourni par la source)

16 citations Journal of Innate Immunity
Accès ouvert 2023 article OpenAlex

Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line

John E. Mamatis, Carla E. Gallardo-Flores, Ujjwal Sangwan, Trinity H. Tooley et autres

The development of antivirals with an extended spectrum of activity is an attractive possibility to protect against future emerging coronaviruses (CoVs). Cyclosporine A (CsA), a clinically approved immunosuppressive drug, has established antiviral activity against diverse unrelated viruses, including several CoVs. However, its …

ca (code pays fourni par la source)

6 citations Antiviral Research
Accès ouvert 2023 preprint OpenAlex

Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line

John E. Mamatis, Carla E. Gallardo-Flores, Taylor Walsh, Ujjwal Sangwan et autres

Abstract The development of antivirals with an extended spectrum of activity is an attractive possibility to protect against future emerging coronaviruses (CoVs). Cyclosporine A (CsA), a clinically approved immunosuppressive drug, has established antiviral activity against diverse unrelated viruses, including several CoVs. However, …

ca (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2022 article OpenAlex

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia

Stephen L. Archer, Asish Dasgupta, Kuang‐Hueih Chen, Danchen Wu et autres

Rationale Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and bioenergetic impairment, and impairing …

ca (code pays fourni par la source)

59 citations Redox Biology
Accès ouvert 2022 article OpenAlex

Emerging Roles of Cyclophilin A in Regulating Viral Cloaking

John E. Mamatis, Isabella E. Pellizzari-Delano, Carla E. Gallardo-Flores, Che C. Colpitts

Cellular cyclophilins (Cyps) such as cyclophilin A (CypA) have emerged as key players at the virus-host interface. As host factors required for the replication of many unrelated viruses, including human immunodeficiency virus (HIV), hepatitis C virus (HCV) and coronaviruses (CoVs), Cyps are …

ca (code pays fourni par la source)

24 citations Frontiers in Microbiology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.